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Abstract 
Objectives The objective of this study was to identify and compare cancer sites whose incidence is 
influenced by social deprivation. 
Methods The study population comprised 189 144 cases of cancer diagnosed between 2006 and 2009, 
recorded in member registries of the French Network of Cancer Registries. Social environment was 
assessed at an aggregate level using the European Deprivation Index (EDI). The association between 
incidence and socioeconomic status was assessed by a geographical Bayesian Poisson model 
permitting to reduce the overall variability and to smooth the relative risks by sharing information 
provided by multiple geographic units. 
Results For cancers of the stomach, liver, lips-mouth-pharynx and lung, a higher incidence in deprived 
populations was found for both sexes as well as for cancers of the larynx, esophagus, pancreas and 
bladder in males and cervical cancer in females. For melanoma, prostate, testis, ovarian and breast, a 
higher incidence in affluent populations was observed. The highest relative risks of the lowest social 
class compared with the highest social class were found for larynx (RR=1.67 [1.43;1.95]), lips-mouth-
pharynx (RR=1.89 [1.72;2.07]) and lung (RR=1.59 [1.50;1.68]) in males and for cervix (RR=1.62 
[1.40;1.88]) and lips-mouth-pharynx (RR=1.56 [1.30;1.86]) in females.  
Conclusions By estimating the burden of social deprivation on cancer incidence throughout France, 
this study enables us to measure the gains that could be obtained by implementing targeted 
prevention efforts.  
Keywords: Cancer incidence, Deprivation, Social environment, Site-specific approach, Cancer 
registries, Bayesian modeling 
 
Introduction 
For many years, large health inequalities have been observed in developed countries, even in countries 
that have egalitarian health systems. These inequalities find their means of expression through various 
chronic diseases such as cardiovascular disease, respiratory disease, diabetes, cancer and many others. 
In France, cancer is the cause of death that best reveals the social inequalities in health (Mackenbach 
et al., 2008). Continual observation of the relationship between socioeconomic status and cancer 
mortality is a fundamental tool for public surveillance and implementation of preventive measures. In 
France, one of the priorities announced in the Cancer Plan 2014--2019 is to “study the geographical 
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and socioeconomic disparities in incidence and survival of cancer using social deprivation indices” (Plan 
Cancer 2014-2019). 
Concerning social disparities in cancer incidence, some relationships going in both directions are 
already well known. Cancer sites associated with low social status usually include lung (Eberle et al., 
2010; Hystad et al., 2013; Hwang et al., 2013; Boscoe et al., 2014; Sharpe et al., 2014) upper aero-
digestive tract (Dalton et al., 2008; Eberle et al., 2010; Boscoe et al., 2014; Sharpe et al., 2014), liver 
(Boscoe et al., 2014; Sharpe et al., 2014), cervix (Dalton et al., 2008; Benard et al. 2008; Eberle et al., 
2010; Boscoe et al., 2014), bladder (Eberle et al., 2010), stomach (Dalton et al., 2008; Boscoe et al., 
2014) and esophagus (Dalton et al., 2008; Levi et al., 2013; Boscoe et al., 2014); those associated with 
high social level include breast (Robert et al., 2004; Dalton et al., 2008; Eberle et al., 2010; Boscoe et 
al., 2014), prostate (Dalton et al., 2008; Cheng et al., 2009; Eberle et al., 2010; Boscoe et al., 2014) and 
melanoma (Dalton et al., 2008; Eberle et al., 2010; Hausauer et al., 2011 ; Boscoe et al., 2014). 
However, few studies examining the relationship between socioeconomic status and cancer incidence 
have been conducted in Europe, and existing studies often covering only one specific site. From a public 
health point of view, it is important to compare the extent of the influence of social deprivation on the 
incidence of various cancers, to implement those preventive measures that will have the greatest 
impact on public health. 
Measuring and comparing the impact of social deprivation on cancer incidence between countries and 
over time will facilitate development of more efficient national and supranational policies to tackle 
social inequalities. Such comparison requires reliable, accurate and comparable data on the cancer 
incidence and socioeconomic environment of the population. Regarding incidence, the increasing 
international standardization of rules for cancer registration creates valuable data provided by cancer 
registries, for use now and in the future. With respect to socioeconomic environment, because 
individual socioeconomic data are often absent or poorly collected in routine health databases, 
individual social status is often assessed using socioeconomic characteristics of the place of residence 
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(Krieger et al., 1997). Townsend demonstrated the relevance of the concept of relative deprivation 
and the necessity of taking into account both the objective and subjective dimensions of poverty 
(Townsend, 1987). From a European perspective, the recent European Deprivation Index (EDI), which 
incorporates such concepts into its construction, permits socioeconomic environment measures to be 
compared or at least makes them transferable between different European countries, despite 
sociocultural differences (Pornet et al., 2012). Moreover, when patient addresses are available, the 
EDI is usable at the smallest geographic level for which census data are available. In France, patient 
addresses have been routinely recorded in cancer registries since 2006, thereby enabling, after 
geocoding, examination of the relationship between social environment and cancer incidence and its 
evolution over time, at a very small geographic scale. 
The objective of this study was to investigate the link between socioeconomic environment and 
incidence for the 15 most frequent solid tumors and three most frequent hematopoietic malignancies 
in France by using a Bayesian model taking into account the geographic nature of the data. 
Methods 
Study population 
The study population consisted of all diagnosed cancer cases that were recorded in member registries 
of the French Network of Cancer Registries (FRANCIM) between 1 January 2006 and 31 December 
2009. The population of the area covered by the registries was about 12 million people (5 778 595 men 
and 6 137 751 women), representing 20% of the French population. For the general registries of 
Gironde and Lille and its region only cancer cases diagnosed between 1 January 2008 and 31 December 
2009 were analyzed (no data were available before this date). For reasons of statistical power, only 
the 15 most frequent solid tumors and the three most frequent hematopoietic malignancies in men 
and women were analyzed (Table 1). These sites were determined using an estimate of the incidence 
of cancer for France (Binder-Foucard et al., 2013). The quality and completeness of records of member 
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registries of the FRANCIM network are evaluated every 4 years by the National Committee of 
Registries. The quality of French registry data is regularly checked by international authorities (IARC; 
International Association of Cancer Registries) for international studies (EUROCARE, CONCORD). The 
cancer sites considered were defined according to codes of the International Classification of Diseases 
for Oncology, 3rd Edition (ICD-O-3; Table 1). The total population included 189 144 cancer cases (Table 
1).  
Data 
For all diagnosed cancers, patient addresses were geolocalized using Geographic Information Systems 
(ArcGIS 10.2) and assigned to an IRIS, a geographical area defined by INSEE (Institut National de la 
Statistique et des Etudes Economiques). An IRIS is the smallest geographic unit for which census data 
are available, an essential factor in this type of study to minimize ecological bias (Krieger et al., 2002). 
The study area included 9740 IRIS. The municipalities of at least 10 000 inhabitants and a high 
proportion of municipalities from 5 000 to 10 000 inhabitants were divided into IRIS. Each IRIS included 
approximately 2 000 individuals with relatively homogeneous social characteristics.  It was built from 
geographical and statistical criteria and, if possible, each IRIS had to be homogeneous from the 
perspective of the habitat. 
The reference populations came from the INSEE national census in 2006, 2007, 2008 and 2009. These 
were given for each IRIS, each sex and each age group: (0-14, 15-29, 30-44, 45-59, 60-74, 75 and more). 
The French version of the European Deprivation Index (EDI) based on the 2007 national census was 
used to assign a deprivation score to each IRIS (Pornet et al., 2012). The methodology used an 
individual deprivation indicator from the conceptual definition of deprivation and selected ecological 
census variables that are the most closely related to the individual deprivation indicator in the 
European Union Statistics on Income and Living condition (EU-SILC). The continuous version or the 
categorical version (national quintiles) of the EDI was used alternatively according to the method used. 
Regarding the national quintiles, 23.77% of the study population was in quintile 1 (least deprived), 
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21.06% was in quintile 2, 20.24% was in quintile 3, 18.22% was in quintile 4 and 16.71% of the study 
population was in quintile 5 (most deprived) meaning that the study population was less deprived than 
the national population. 
Statistical analysis 
A Bayesian approach was used rather than a classical Poisson regression because this allowed the 
integration of extra-Poisson variability if it existed in the data (Pascutto et al., 2000; Colonna, 2002). 
Using the classical Poisson model in the aggregate geographical studies, as has been done for existing 
studies, may cause an underestimation of the standard error because overdispersion defined as 
variability in the number of cases higher than expected by the Poisson distribution is not taken into 
account. The differences in population sizes between IRIS units, called unstructured spatial 
heterogeneity, may have introduced variations; this methodology permitted the distinction between 
random fluctuations and true variations in incidence rates. Moreover, neighboring areas could not be 
independent and had similar incidence rates. This phenomenon, called spatial autocorrelation, was 
also integrated with the Bayesian analysis using WinBUGS version 1.4. We estimated the regression 
coefficient associated with the variable EDI and its 95% credible interval. A positive parameter related 
to EDI means an over-incidence in disadvantaged areas, and a negative parameter related to EDI means 
an over-incidence in favored areas. The analysis was conducted by department and for all available 
data.  To determine whether spatial autocorrelation and spatial heterogeneity were actually present 
in the data, we first performed the Moran test (Wakefield et al., 2000) for autocorrelation and the 
Potthoff-Whittinghill (Potthoff and Whittinghill, 1966) test for heterogeneity. These were done using 
packages spdep and DCluster from R version 2.15.0. According to the results of the tests, we applied a 
Besag-York- Mollié (BYM) model integrating the two components or a conditionnal autoregressive 
(CAR) model integrating the spatially structured heterogeneity or a model with the non-spatially 
structured heterogeneity. If both tests were non-significant, meaning that there was no variability of 
incidence in the data, the EDI was not included in the analysis. We performed this analysis first using 
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first the continuous version of the EDI and then the categorical version of the EDI, to detect if a 
nonlinear trend existed. For the categorical analysis, the less deprived category was considered the 
reference category. 
Results 
A total 189 144 cancer cases were analyzed, with 100 299 men and 78 845 women. These cancers were 
divided according to the 16 analyzed departments. 
Tables 2 and 3 present the results of analysis using the continuous version of the EDI obtained with all 
available data. The Potthoff-Whittinghill test was non-significant for the majority of sites in both sexes. 
Moran test was significant for all sites in both males and females, which confirms a geographical 
structure in the data and justified modeling. A statistically significant higher incidence among 
disadvantaged individuals was observed for cancers of the stomach, liver, lips-mouth-pharynx and lung 
in both sexes. This significant over-incidence was also found for cancers of the larynx, esophagus, 
pancreas and bladder in men and for cervical cancer in women. A significantly higher incidence in 
advantaged individuals was observed for melanoma in both sexes. This significant over-incidence was 
also found for prostate and testicular cancers in men, and ovarian and breast cancers in women. By 
examining the values of the coefficient estimates associated with the EDI variable, this link between 
deprivation and incidence was particularly strong for cancers of the larynx, lips-mouth-pharynx and 
lung and for melanoma (with a negative sign) in men, and for cancers of the cervix, stomach, liver, lips-
mouth-pharynx and for melanoma (with a negative sign) in women. 
Supplementary Tables S1 and S2 summarize the analysis results for each department in males and 
females. For stomach, liver, lips-mouth-pharynx and lung sites, for which a significant positive 
association with deprivation was found in the global analysis, the trend was similar in the majority of 
areas. Similar observation was made for melanoma, prostate and breast with a negative association. 
A negative association manner was found for ovary and thyroid for females in a majority of areas but 
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never in a significant manner, with a similar observation made for the central nervous system in males. 
Conflicting results, with positive and negative association depending on area, were found for colon-
rectum, pancreas, kidney, bladder and hematopoietic sites.  
Tables 4 and 5 present the results of analysis using the categorical version of the EDI (estimation and 
95% credible interval). Figure 1 graphically represents the relative risks of the most disadvantaged 
group (under the fifth quintile of the EDI) compared with the most favored group (above the first 
quintile of the EDI). Relative risk was more than 1.5 for lips-mouth-pharynx, larynx and lung sites in 
males, and for cervix and lips-mouth-pharynx in females; the other significant relative risk were found 
for liver and stomach sites in both sexes. Melanoma exhibited the highest inverse relative risk with 
deprivation for both sexes, with ovary, breast, and prostate being the other sites inversely associated 
in a significant way; the testis site was borderline. 
Discussion 
Based on data from the national network of cancer registries gathering standardized data from 16 
different departments, our results provide a comprehensive assessment of the relationship between 
socioeconomic status and cancer incidence in France for 18 cancer sites. In men, eight sites were 
associated with social deprivation, and three sites associated with social affluence; corresponding 
figures were five sites and three sites in women. The relative risks were particularly strong for cancers 
of the larynx, lips-mouth-pharynx, esophagus, lung and cervix; those associated with social affluence 
were strong for melanoma and ovarian cancer. The impact of deprivation on cancer incidence was 
more important in males than in females. Even if the association with social environment was slight, 
because of their high incidence, prostate and breast cancers exhibited a high number of excess cases 
associated with social affluence. 
Not surprisingly, cancers related to smoking, alcohol use and infections were found in excess in 
deprived populations. Such risky behaviors are more common in socially disadvantaged areas 
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(Shohaimi et al., 2004; Adimora and Schoenbach, 2005; Baumann et al., 2007; Meffre et al., 2010; 
Lakshman et al., 2011) and may explain the over-incidence of cancers of the lung, upper aerodigestive 
tracts, liver, bladder, cervix, stomach and esophagus. The link between deprivation and pancreatic 
cancer risk is less documented, but the same risk factors exist, i.e., tobacco use, infections and food 
quality (Maisonneuve and Lowenfels, 2014). Our results showed an over-incidence of other cancers in 
favored areas, such as prostate, breast and melanoma. For breast cancer and melanoma, such over-
incidence can be partly explained by the social determinants of some risk factors, such as older age at 
birth of first child for breast cancer and exposure to UV radiation for melanoma. Importantly for 
prostate cancer, and to a lesser extent for breast cancer, the over-incidence is explained by the greater 
adherence in favored populations to screening, which leads to over-diagnosis (Morgan et al., 2013); 
over-diagnosis is defined as the detection of asymptomatic tumors that would not have been detected 
without a screening test and would not have caused symptoms, morbidity or death during a person’s 
lifetime. The link between ovarian and testicular cancer risk and social affluence is less documented. 
Risk factors for ovarian cancer are strongly linked to reproductive risk factors, including older age at 
birth of first child, a smaller number of children and short periods of breastfeeding (Cramer, 2012). 
Risk factors for breast cancer, which are partly socially determined, can explain the over-incidence in 
the affluent population. Knowledge about the epidemiology of testicular cancer is even more 
uncertain; risk factors being investigated include certain exposures during pregnancy or infancy, 
certain occupations such as firefighting, or exposure to certain pesticides (McGlynn and Trabert, 2012). 
Recent studies have highlighted the relationship between social affluence and risk of developing 
testicular cancer (Schmeisser et al., 2013; Boscoe et al., 2014) but have not provided concrete 
explanations about the origin of such a relationship. Concerning colorectal cancer, previous studies 
show conflicting results. Some have found that the incidence of this cancer is associated with lower 
social class (Aarts et al., 2010; Boscoe et al., 2014) which can be explained by more risky behaviors in 
this population (food quality). Other studies have found that the incidence is associated with higher 
social status (Eberle et al., 2010), explained by the greater participation in colorectal cancer screening. 
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In our study, we found no association between deprivation and colorectal cancer incidence, with 
relative risks very close to 1, which hinders clarification of this contradiction. We can assume that the 
two conflicting influences lead to cancelation of any relationship. 
Our study has some limitations. First, although our study population included all cases of cancer 
recorded in French registries between 2006 and 2009, this covers only 20% of the French population, 
major French cities (Paris, Marseille, Lyon) are not covered by the registries, and the study area is not 
representative of the national territory for deprivation. Indeed, registries in France are defined at the 
local level and a national registry does not exist. Second, our study period started in 2006, when 
registries began to routinely record patient addresses for geocoding to assign each patient to an IRIS. 
Shortening the study period allowed us to include all the French registries, but prevented us from 
conducting temporal trend analysis. Despite the diversity and number of territories covered in the 
analysis may result in great heterogeneity of results, in fact, this was not the case. By comparing the 
analyses by department, similar results were obtained, suggesting comparability in terms of cancer 
registration between registries and lending consistency to our results. Moreover, this comparison 
didn’t allow us to highlight a particular social situation in departments, for instance, regional measures 
for screening and prevention. 
Some methodological aspects can be discussed. First, our study design used aggregate data at the IRIS 
level, with an ecological index of social deprivation. Although this type of index presents many 
advantages such as applicability to all populations, thus preventing selection bias, its main weakness 
is unavoidable ecological bias because the same score is assigned to all people living in the same area. 
However, this bias is limited by the use of IRIS, which is the smallest geographic level with available 
census data.23 Moreover, the relevance of ecological indices is not confined to being a “proxy” of 
individual social characteristics, because the potential effects of social characteristics of areas 
themselves are integrated, i.e., contextual effects. For example, with respect to lung cancer, such an 
index can account for the potentially higher levels of air pollution in deprived areas (Naess et al., 2007). 
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In addition, the EDI used in this paper integrates subjective and objective dimensions of poverty. The 
EDI is based on the pioneering Townsend index concept of relative deprivation and is constructed with 
a common European database, enabling international analyses in Europe to be compared. The spatial 
nature of the data and its specificities (spatial autocorrelation and non-spatially structured 
heterogeneity) was accounted in our modeling thanks to the Bayesian approach ensuring a good 
consistency of the statistical analysis. Thus use of a classical Poisson regression would have risked to 
underestimate the standard error and to wrongly conclude at a significant effect of deprivation on 
cancer incidence (Haining et al., 2009). 
Since the most important relative risks are observed for cancers of the lung, lips-mouth-pharynx and 
larynx, our results suggest that tobacco, which has already been identified as the number one enemy 
of public health, is also the most important carrier of social inequalities in cancer incidence. Moreover, 
since these socially determined cancers are also those with the poorest prognosis, which decreases 
further down the social scale, the social inequalities in incidence brought about by tobacco are also at 
the root of social inequalities in cancer mortality. To tackle such inequalities, our results therefore 
reinforce the urgent need to strengthen prevention efforts focused on tobacco consumption in the 
most at-risk populations. We must be aware that such prevention policies should act on inequalities 
themselves and therefore on the disadvantaged environment by increasing urbanization, transport, 
employment and not be limited to health interventions such as for reimbursement of nicotinic 
substitutes for example. Other risk factors should also be subject to specific measures, such as alcohol 
consumption, occupational risk factors and sexual risk factors, although with less urgency than 
tobacco. Concerning sites with over-incidence in affluent areas, it appears that individual over-risks 
are quite low; however, the impact on public health is important because the cancer sites concerned 
are the most frequent in the population (prostate and breast cancers). It is therefore important to 
measure the factors responsible for this phenomenon, such as over-diagnosis. 
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By estimating the burden of social deprivation on cancer incidence with a site-specific approach, it is 
possible to better identify the kinds of public health measures appropriate for reducing social 
inequalities. The use of geographical approaches with relevant deprivation indices also permits us to 
better identify populations that should be targeted in such prevention efforts. 
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Figure legend 
Figure 1 Relative risks of the most deprived category compared with the most affluent category and 
its 95% credible interval in men and in women 
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Table 1 Site definition and frequencies in member registries of the FRANCIM network between 2006 and 2009 
Site ICD-O-3a  Frequencies   
 Topographyb Morphologyb Men Women Total 
Colon-Rectum C18, C19, C20, C21 All 15747 12841 28588 
Cervix C53 All  1823 1823 
Uterus C54 All  3860 3860 
Stomach C16 All 3296 1840 5136 
Liver C22 All 4720 1043 5763 
Larynx C32 All 1735  1735 
Lips-Mouth-Pharynx C0, C10, C11, 
C12, C13, C14 
All 5859 1469 7328 
Lymphocytic leukemia All 98233 1538 1086 2624 
Diffuse large-B-cell lymphoma All 96803 1359  1359 
Melanoma C44 87203-87803 2950 3420 6370 
Myeloma All 97313-97343 or 1817 1535 3352 
  97603-97643    
Esophagus C15 All 3128  3128 
Ovary C56 All excluding  2721 2721 
  {84423; 84513;    
  84613; 84623;    
  84723; 84733}    
Pancreas C25 All 3130 2950 6080 
Lung C33, C34 All 14908 4451 19359 
Prostate C61 All 34223  34223 
Kidney C64, C65, C66 All 6175 2068 8243 
Breast C50 All  29600 29600 
Central nervous system C70, C71, C72 ≤ 91103 or ≤ 91800 2172 2486 4658 
      
Myelodysplasic syndrome All 99803,99823,  1090 1090 
  99833,99853,    
  99863,99873,    
  99893    
Testis C62 All 1245  1245 
Thyroid C73 All 1040 3291 4331 
Bladder C67 All 5257 1271 6528 
a ICD-O-3: International Classification of Diseases for Oncology, 3rd Edition 
b Hematological codes are always excluded from solid tumor sites and included in the relevant hematological site 
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Table 2 Influence of socioeconomic status on incidence of cancers in men, in French registries between 2006 and 2009 
Site  PWa test Estimationb 
EDI coefficient 
CIc (95%) 
Colon-Rectum  0.005 0.003 [-0.002;0.007] 
Stomach  0.239 0.022 [0.013;0.031] 
Liver  0.139 0.023 [0.015;0.030] 
Larynx  0.346 0.035 [0.023;0.046] 
Lips-Mouth-Pharynx  0.001 0.048 [0.042;0.055] 
Lymphocytic leukemia  0.455 -0.006 [-0.021;0.008] 
Diffuse large-B-cell lymphoma  0.756 -0.004 [-0.019;0.011] 
Melanoma  0.431 -0.042 [-0.053;-0.031] 
Myeloma  0.275 0.004 [-0.0090;0.016] 
Esophagus  0.010 0.027 [0.017;0.037] 
Pancreas  0.250 0.011 [0.001;0.020] 
Lung  0.001 0.039 [0.034; 0.043] 
Prostate  0.016 -0.015 [-0.018;-0.011] 
Kidney  0.029 -0.007 [-0.014; 0.001] 
Central nervous system  0.717 -0.006 [-0.017;0.006] 
Testis  0.786 -0.015 [-0.029;-0.001] 
Thyroid  0.246 0.006 [-0.010;0.021] 
Bladder  0.031 0.016 [0.008;0.023] 
a Potthoff-Whittinghill. 
b Estimation of the coefficient related to EDI (European Deprivation Index). Positive for over-incidence in deprived areas, 
negative otherwise. 
c Significant CIs (credible intervals) are in bold type. 
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Table 3 Influence of socioeconomic status on incidence of cancers in women, in French registries between 2006 and 2009 
Site  PWa test Estimationb 
EDI coefficient 
CIc (95%) 
Colon-rectum  0.001 0.001 [-0.005;0.005] 
Cervix  0.446 0.034 [0.024;0.044] 
Uterus  0.419 -0.006 [-0.015;0.003] 
Stomach  0.099 0.031 [0.019;0.043] 
Liver  0.828 0.040 [0.025;0.054] 
Lips-Mouth-Pharynx  0.031 0.033 [0.021;0.045] 
Lymphocytic leukemia  0.748 -0.004 [-0.021;0.012] 
Melanoma  0.197 -0.037 [-0.047;-0.027] 
Myeloma  0.403 0.002 [-0.012;0.016] 
Ovary  0.885 -0.019 [-0.030;-0.009] 
Pancreas  0.528 0.008 [-0.002;0.018] 
Lung  0.061 0.028 [0.020;0.035] 
Kidney  0.368 -0.002 [-0.014;0.009] 
Breast  0.073 -0.010 [-0.014;-0.007] 
Central nervous system  0.354 0.005 [-0.006;0.015] 
Myelodysplasic syndrome  0.191 0.003 [-0.014;0.020] 
Thyroid  0.048 -0.002 [-0.011;0.008] 
Bladder  0.002 0.012 [-0.003;0.027] 
a Potthoff-Whittinghill. 
b Estimation of the coefficient related to EDI (European Deprivation Index). Positive for over-incidence in deprived areas, 
negative otherwise. 
c Significant CIs (credible intervals) are in bold type. 
 
 
 
 
 
 
 
 
 
 
20 
 
Table 4: Analysis using the quintile version of EDI in males, in French registries between 2006 and 2009 
Site Social category RR CI (95%) Site Social category RR CI (95%) 
Colon-Rectum Highest social class 1.00  Esophagus Highest social class 1.00  
  1.04 [0.99;1.10]   1.05 [0.94 ;1.19] 
  1.05 [0.99;1.11]   1.14 [1.01 1.28] 
  1.02 [0.97;1.08]   1.29 [1.14;1.45] 
 Lowest social class 1.04 [0.97;1.10]  Lowest social class 1.48 [1.31;1.68] 
Stomach Highest social class 1.00  Pancreas Highest social class 1.00  
  1.02 [0.92;1.14]   0.99 [0.89;1.11] 
  1.00 [0.90;1.12]   1.02 [0.91;1.14] 
  1.08 [0.96;1.21]   0.98 [0.87;1.09] 
 Lowest social class 1.24 [1.11;1.39]  Lowest social class 1.10 [0.98;1.23] 
Liver Highest social class 1.00  Lung Highest social class 1.00  
  1.00 [0.91;1.09]   1.11 [1.05;1.18] 
  1.03 [0.94;1.13]   1.22 [1.15;1.29] 
  1.19 [1.08;1.30]   1.31 [1.23;1.39] 
 Lowest social class 1.25 [1.13;1.37]  Lowest social class 1.59 [1.50;1.68] 
Larynx Highest social class 1.00  Prostate Highest social class 1.00  
  1.19 [1.02;1.39]   0.89 [0.86;0.93] 
  1.24 [1.06;1.46]   0.91  [0.87;0.95] 
  1.33 [1.13;1.56]   0.93 [0.88;0.96] 
 Lowest social class 1.67 [1.43;1.95]  Lowest social class 0.86 [0.83;0.90] 
Lips-Mouth- Highest social class 1.00  Kidney Highest social class 1.00  
Pharynx  1.18 [1.08;1.30]   1.02 [0.95;1.11] 
  1.27 [1.16;1.40]   1.01 [0.93;1.10] 
  1.43 [1.30;1.57]   1.03 [0.95;1.13] 
 Lowest social class 1.89 [1.72;2.07]  Lowest social class 0.96 [0.88;1.05] 
Lymphocytic Highest social class 1.00  Central   Highest social class 1.00  
leukemia  1.00 [0.86;1.17] Nervous  0.88 [0.77;1.01] 
  0.99 [0.85;1.16] System  0.89 [0.78;1.02] 
  0.96 [0.82;1.13]   0.95 [0.83;1.08] 
 Lowest social class 1.00 [0.85;1.18]  Lowest social class 0.92 [0.80;1.05] 
Diffuse large-B- Highest social class 1.00  Testis Highest social class 1.00  
cell lymphoma  1.05 [0.90;1.24]   0.94 [0.79;1.14] 
  0.98 [0.83;1.16]   0.96 [0.79;1.16] 
  0.96 [0.81;1.14]   0.77 [0.65;0.92] 
 Lowest social class 0.97 [0.81;1.15]  Lowest social class 0.85 [1.01;0.71] 
Melanoma Highest social class 1.00  Thyroid Highest social class 1.00  
  0.81 [0.71;0.91]   1.01 [0.84;1.21] 
  0.84 [0.74;0.95]   0.96 [0.79;1.16] 
  0.85 [0.75;0.96]   1.11 [0.84;1.25] 
 Lowest social class 0.72 [0.64;0.81]  Lowest social class 1.04 [0.85;1.26] 
Myeloma Highest social class 1.00  Bladder  Highest social class 1.00  
  1.02 [0.88;1.17]   1.08 [0.98;1.18] 
  1.01 [0.87 1.17]   1.11 [1.01;1.22] 
  1.00 [0.86;1.16]   1.13 [1.03;1.24] 
 Lowest social class 1.00 [0.86;1.16]  Lowest social class 1.22 [1.11;1.34] 
           Abbreviations: EDI: European Deprivation Index; RR: Relative risk; CI, Credible interval                                  
               aRRs calculated with the highest social class as reference 
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Table 5 Analysis using the quintile version of EDI in women, in French registries between 2006 and 2009 
Site Social category RR CI (95%) Site Social category RR CI (95%) 
Colon-rectum Highest social class 1.00  Ovary Highest social class 1.00  
  1.01 [0.95;1.07]   0.82 [0.72;0.93] 
  0.99 [0.93;1.05]   0.80 [0.70;0.90] 
  1.00 [0.94;1.06]   0.79 [0.70;0.89] 
 Lowest social class 1.01 [0.95;1.07]  Lowest social class 0.79 [0.70;0.90] 
Cervix Highest social class 1.00  Pancreas Highest social class 1.00  
  1.21 [1.03;1.41]   1.04 [0.92;1.18] 
  1.27 [1.08;1.48]   1.06 [0.94;1.20] 
  1.21 [1.03;1.42]   1.13 [1.00;1.27] 
 Lowest social class 1.62 [1.40;1.88]  Lowest social class 1.11 [0.99;1.26] 
Uterus Highest social class 1.00  Lung Highest social class 1.00  
  0.98 [0.89;1.09]   1.12 [1.01;1.24] 
  1.01 [0.91;1.12]   1.13 [1.02;1.26] 
  0.96 [0.87;1.07]   1.24 [1.12;1.37] 
 Lowest social class 0.97 [0.87;1.07]  Lowest social class 1.35 [1.22;1.49] 
Stomach Highest social class 1.00  Kidney Highest social class 1.00  
  1.16 [1.00;1.36]   1.13 [0.99;1.30] 
  1.16 [0.99;1.35]   1.03 [0.89;1.18] 
  1.24 [1.06;1.45]   1.01 [0.87;1.16] 
 Lowest social class 1.40 [1.20;1.63]  Lowest social class 1.00 [0.87;1.16] 
Liver Highest social class 1.00  Breast Highest social class 1.00  
  1.03 [0.84;1.27]   0.91 [0.88;0.94] 
  1.15 [0.94;1.41]   0.94 [0.91;0.98] 
  1.11 [0.91;1.37]   0.95 [0.91;0.99] 
 Lowest social class 1.45 [1.19;1.77]  Lowest social class 0.93 [0.89;0.96] 
Lips-Mouth- Highest social class 1.00  Central Highest social class 1.00  
Pharynx  1.15 [0.96;1.38] Nervous  1.06 [0.93;1.21] 
  1.29 [1.08;1.55] System  1.07 [0.94;1.21] 
  1.48 [1.24;1.76]   1.10 [0.97;1.25] 
 Lowest social class 1.56 [1.30;1.86]  Lowest social class 1.10 [0.97;1.25] 
Lymphocytic Highest social class 1.00  Myelodysplasic Highest social class 1.00  
leukemia  1.08 [0.89;1.30] Syndrom  1.02 [0.83;1.24] 
  0.99 [0.81;1.20]   0.91 [0.74;1.11] 
  0.95 [0.78;1.16]   1.04 [0.86;1.27] 
 Lowest social class 0.96 [0.79;1.17]  Lowest social class 0.93 [0.76;1.14] 
Melanoma Highest social class 1.00  Thyroid Highest social class 1.00  
  0.79 [0.70;0.88]   0.98 [0.88;1.10] 
  0.82 [0.73;0.93]   0.91 [0.81;1.02] 
  0.82 [0.73;0.93]   0.95 [0.85;1.07] 
 Lowest social class 0.71 [0.64;0.80]  Lowest social class 0.96 [0.85;1.08] 
Myeloma Highest social class 1.00  Bladder Highest social class 1.00  
  1.11 [0.94;1.31]   0.95 [0.79;1.15] 
  1.09 [0.93;1.19]   0.97 [0.80;1.17] 
  1.07 [0.90;1.26]   1.07 [0.89;1.29] 
 Lowest social class 1.09 [0.92;1.19]  Lowest social class 1.08 [0.90;1.31] 
               Abbreviations: EDI: European Deprivation Index; RR: Relative risk; CI, Credible interval                                  
               aRRs calculated with the highest social class as reference 
 
 
 
